Aerobic and resistance training do not influence plasma carnosinase content or activity in type 2 diabetes.

about

How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?

P2860

Q37636114-568ED858-B7B9-40C6-9C92-8C69B536FF14

P2860

Aerobic and resistance training do not influence plasma carnosinase content or activity in type 2 diabetes.

Item

http://www.wikidata.org/entity/Q40519605

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Aerobic and resistance trainin ...... r activity in type 2 diabetes.

@en

type

Item

label

Aerobic and resistance trainin ...... r activity in type 2 diabetes.

@en

prefLabel

Aerobic and resistance trainin ...... r activity in type 2 diabetes.

@en

P1476

Aerobic and resistance trainin ...... r activity in type 2 diabetes.

@en

P2093

Benito Yard

http://www.w3.org/2001/XMLSchema#string

Emile De Heer

http://www.w3.org/2001/XMLSchema#string

Farah Khandwala

http://www.w3.org/2001/XMLSchema#string

Glen P Kenny

http://www.w3.org/2001/XMLSchema#string

Ronald J Sigal

http://www.w3.org/2001/XMLSchema#string

Sanne Stegen

http://www.w3.org/2001/XMLSchema#string

P2860

Physiology and pathophysiology of carnosine.

Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Association between CNDP1 genotype and diabetic nephropathy is sex specific.

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.

N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia

Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium.

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.

L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.

P304

E663-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00142.2015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P50

Wim Derave

Wim Peersman

Hans Baelde

P577

2015-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282049043

http://www.w3.org/2001/XMLSchema#string

P698

26389600

http://www.w3.org/2001/XMLSchema#string

Aerobic and resistance training do not influence plasma carnosinase content or activity in type 2 diabetes.

about

P2860

P2860

Aerobic and resistance training do not influence plasma carnosinase content or activity in type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698